ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia

QR Code

ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia

Introduction: Acute myeloid leukaemia (AML) is a heterogeneous malignant disease with a high degree of treatment failure using chemotherapy. Leukaemia stem cells (LSCs) are CD34+CD38- early progenitors associated with poor prognosis in AML. A unique LSC phenotype that excludes rare normal haematopoi...

Full description

Bibliographic Details
Main Authors:	Mohd Amin, A, Panneerselvan, N, Md Noor, S, Mohtaruddin, N, Sathar, J, Norbaya, WS, Osman, R, Kee, LH, Mohd Yaaku, WH, Cheong, SK, Abdullah, M
Format:	Article
Published:	Malaysian Society of Pathologists 2023
Online Access:	http://psasir.upm.edu.my/id/eprint/107715/

Similar Items

Expression of potential stem cell-related markers in acute myeloid leukaemia cell lines and gene silencing effect of HOXA3 in THP-1 cells
by: Panneerselvan, Hindhuja
Published: (2021)

Less utilized prognostic markers in acute myeloid leukaemia
by: Abdullah, Maha
Published: (2016)

Targeting dormancy in acute myeloid leukaemia
by: Doolan, Lara
Published: (2023)

Identifying and targeting dormant cells in acute myeloid leukaemia
by: Yu, N.
Published: (2016)

Recent advances in diagnosis of acute myeloid leukaemia : a review.
by: Ambayya, Angeli, et al.
Published: (2013)

Proteomic profile of acute myeloid leukaemia: a review update
by: Almaiman, Amer Abdulrahman, et al.
Published: (2016)

Identification of differentially expressed proteins as biomarkers of acute myeloid leukaemia
by: Barantalab, Fatemeh
Published: (2014)

Selection of reference genes for quantitative studies in acute myeloid leukaemia
by: Lee, Cindee, et al.
Published: (2019)

Cell viability of acute myeloid leukaemia blasts in culture correlates with treatment outcome
by: Abdullah, Maha, et al.
Published: (2008)

Targeting HOXA in engineered iPSCs and pre-clinical leukaemia models
by: Abuhantash, Mays
Published: (2023)

Prognostic Markers Of Resistance And Relapse In Acute Leukaemia
by: Pon, Maha Abdullah@Maha-Lakswmi
Published: (2003)

Activity of the aurora kinase B inhibitor AZD1152 in acute myeloid leukaemia
by: Grundy, Martin
Published: (2012)

Plasma and cell lysate proteins associated with treatment outcome in acute myeloid leukaemia
by: Barantalab, Fatemeh, et al.
Published: (2020)

Investigation of dormancy in acute myeloid leukaemia cells and the induction of dormancy in their response to genotoxic stress
by: Al-Asadi, Mazin Gh.
Published: (2017)

Arginine dependence of acute myeloid leukaemia blast proliferation: a novel therapeutic target
by: Mussai, Francis, et al.
Published: (2015)

Utilization of chemotherapy regimen for acute myeloid leukaemia patients in Ampang Hospital / Jamaliah Jamari
by: Jamari, Jamaliah
Published: (2015)

Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort
by: Ghassemifar, Reza, et al.
Published: (2011)

Efficacy of dendritic cell-based vaccine on acute myeloid leukaemia in a murine model
by: Ng, Wei Yi
Published: (2013)

Evaluating a rapid method to quantify multiple gene expression in acute myeloid leukaemia
by: Lee, Cin Dee
Published: (2013)

Cockle shell-derived nano carrier for Ara-C in the treatment of acute myeloid leukaemia
by: Ghaji, Mustafa Saddam
Published: (2018)

Gene Expression Profile And Modulation Of Genetic Pathways In Acute Myeloid Leukaemia T(8;21)
by: Bashanfer, Salem Ali Alsalem
Published: (2013)

Expression of survival and apoptotic molecules in response to early stage chemotherapy in acute myeloid leukaemia
by: Yiau, Stephnie Kang Xian
Published: (2013)

A molecular signature of dormancy in CD34+CD38- acute myeloid leukaemia cells
by: Al-Asadi, Mazin Gh., et al.
Published: (2017)

Microarray-based genomic analysis identifies germline and somatic copy number variants and loss of heterozygosity in acute myeloid leukaemia
by: Ambayya @ Ampiah, A Angeli, et al.
Published: (2018)

DNA damage response and anti-apoptotic proteins expression in NPMc+ mutated cells in acute myeloid leukaemia
by: Qutob, Haitham
Published: (2014)

Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
by: Chen, Li-Chia, et al.
Published: (2014)

FLT3, NPM1, DNMT3a and NRAS genes mutation in acute myeloid leukaemia in HUSM
by: Mat Yunus, Noraini
Published: (2015)

The Clinical Significance Of Npm1, Flt3 And Cebpa Gene Mutations In Adult Patients With Acute Myeloid Leukaemia
by: Ul Haq, Izaz
Published: (2020)

Elucidating the genomic and transcriptomic profiles contributing to the overall survival of acute myeloid leukaemia patients with normal karyotype in Malaysia
by: Ambayya @ Ampiah, A Angeli
Published: (2024)

The prognostic impact of CD7 expression of leukaemic blasts in de novo intermediate cytogenetic risk acute myeloid leukaemia.
by: Kesavan, M., et al.
Published: (2016)

Microarray-based genomic analysis identifies germline and somatic copy number variants and loss of heterozygosity in acute myeloid leukaemia
by: Ambayya @ Ampiah, A Angeli
Published: (2015)

The mechanism of action of the negative Regulators of jak/stat singnaling pathway in Resistant FLT-ITD acute myeloid leukaemia cells
by: Johan, Muhammad Farid
Published: (2019)

A case of Bickerstaff brainstem encephalitis and acute lymphoblastic leukaemia
by: Hashim, Hasriza, et al.
Published: (2014)

Detection of leukaemia-associated aberrant immunophenotype (LAIPs) in acute leukaemia and its association with haematological parameters and treatment outcome
by: Rahman, Noor Shaidatul Akmal Ab
Published: (2017)

The cytotoxicity effect of ant-444 in human chronic myeloid leukaemia cells (K 562)
by: Khalid, Nor Bahijah, et al.
Published: (2013)

Generation, Phenotyping and Functional Analysis of Dendritic Cells (DC) Derived from Human Monocytes and Acute Myeloid Leukaemia (AML) Cells
by: Lim, Moon Nian
Published: (2004)

The immunotype of acute leukaemia in Kelantan as determined by flow cytometry
by: Dasgupta, Anil, et al.
Published: (1999)

Treatment outcome of children with acute lymphoblastic leukaemia in HUSM
by: Nik Nasiruddin, Nik Leh
Published: (2007)

S-phase fraction and pro-inflammatory cytokine expressions in acute lymphoblastic leukaemia
by: Abdullah, Maha, et al.
Published: (2005)

Molecular and immunophenotyping characteristics of non-APML, CD34 and HLA-DR negative acute myeloid leukaemia (HLA-DRneg non-APML)
by: Seman, Zainina, et al.
Published: (2024)